Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC1419 | HER2amp | Luminal | Mebendazole | 0.000853 | uM | 12612.174 | 0.9569 | 0.8575 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 0.00427 | uM | 12612.174 | 0.9713 | 0.9048 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 0.0213 | uM | 12612.174 | 0.9509 | 0.8379 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 0.107 | uM | 12612.174 | 0.9618 | 0.8733 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 0.533 | uM | 12612.174 | 0.9210 | 0.7421 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 2.67 | uM | 12612.174 | 0.8714 | 0.5876 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 13.3 | uM | 12612.174 | 0.8624 | 0.5604 | 0.5962 | |||
| HCC1419 | HER2amp | Luminal | Mebendazole | 66.7 | uM | 12612.174 | 0.7692 | 0.2878 | 0.5962 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 0.000171 | uM | 13107.174 | 0.9972 | 0.9917 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 0.000853 | uM | 13107.174 | 0.9507 | 0.8550 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 0.00427 | uM | 13107.174 | 0.9785 | 0.9365 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 0.0213 | uM | 13107.174 | 0.9420 | 0.8300 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 0.107 | uM | 13107.174 | 0.9893 | 0.9682 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 0.533 | uM | 13107.174 | 0.8873 | 0.6743 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 2.67 | uM | 13107.174 | 0.8560 | 0.5870 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 13.3 | uM | 13107.174 | 0.8784 | 0.6491 | 0.6723 | |||
| HCC1428 | HR+ | Luminal | Mebendazole | 66.7 | uM | 13107.174 | 0.8180 | 0.4834 | 0.6723 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 0.000171 | uM | 13038.174 | 1.0232 | 1.0384 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 0.000853 | uM | 13038.174 | 0.9602 | 0.9336 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 0.00427 | uM | 13038.174 | 0.8336 | 0.7191 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 0.0213 | uM | 13038.174 | 0.9877 | 0.9794 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 0.107 | uM | 13038.174 | 0.9472 | 0.9118 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 0.533 | uM | 13038.174 | 0.7493 | 0.5733 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 2.67 | uM | 13038.174 | 0.7416 | 0.5598 | 1.2027 | |||
| HCC1569 | HER2amp | Basal A | Mebendazole | 13.3 | uM | 13038.174 | 0.6871 | 0.4640 | 1.2027 |